Literature DB >> 8379453

Neutral sphingomyelinase.

S Chatterjee1.   

Abstract

Although we have accumulated few data that would definitely designate the role of N-SMase in modern cell biology, current evidence indicates that N-SMase may play a central role in signal transduction (Fig. 7). Biomodulators such as hormones, antibiotics, drugs, growth factors, and lipoproteins may interact with N-SMase either directly or in combination with other components (receptors) on the cell surface. The cell surface topology would provide easy access for such interactions. According to our hypothetical model shown in Fig. 7, activation of N-SMase via biomodulators, e.g., TNF-alpha, leads to the mobilization of cell surface cholesterol to the interior of the cell. We speculate that this process may be facilitated by sterol carrier proteins. This phenomenon may alter the lipid bilayer and make N-SMase accessible to its substrate, sphingomyelin. Ceramide released as a consequence of N-SMase reaction would then carry out various biological phenomena, such as cell proliferation and differentiation. Cholesterol on the other hand, may undergo oxidation and inhibit HMG-CoA reductase activity; it may also be utilized by ACAT to form cholesteryl esters. A decrease in cell membrane cholesterol levels may stimulate LDL receptor activity and LDL receptor recycling and/or synthesis. In contrast, inactivation or decreased activity of N-SMase, as in the case of gentamicin-treated cells, may have the opposite effect, i.e., decreased LDL receptor activity and decreased cholesteryl ester synthesis. Thus, N-SMase may indirectly modulate cholesterol metabolism in cells independent of LDL. It can also modify LDL, allowing its rapid uptake and foam cell formation in macrophages. We can safely conclude that N-SMase action may be required to carry out a myriad of important cellular functions either directly or by cholesterol mobilization, or generation of ceramide, ceramide-1-phosphate, and sphingoid bases. The present data support the view that N-SMase action may initiate signal transduction for such biomodulators as growth factors, lipoprotein, and hormones.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8379453

Source DB:  PubMed          Journal:  Adv Lipid Res        ISSN: 0065-2849


  19 in total

1.  Activation of neutral sphingomyelinase in human neutrophils by polyunsaturated fatty acids.

Authors:  B S Robinson; C S Hii; A Poulos; A Ferrante
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

2.  Identification and partial characterization of an acidic sphingomyelinase (SMase) from cultured human umbilical vein endothelial cells (HUVEC).

Authors:  J F Truax; F R Cochran
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

Review 3.  A role for sphingolipids in the pathophysiology of obesity-induced inflammation.

Authors:  Benjamin T Bikman
Journal:  Cell Mol Life Sci       Date:  2012-07       Impact factor: 9.261

4.  Neutral magnesium-dependent sphingomyelinase from liver plasma membrane: purification and inhibition by ubiquinol.

Authors:  S F Martín; F Navarro; N Forthoffer; P Navas; J M Villalba
Journal:  J Bioenerg Biomembr       Date:  2001-04       Impact factor: 2.945

5.  Neutral sphingomyelinase: localization in rat liver nuclei and involvement in regeneration/proliferation.

Authors:  A Alessenko; S Chatterjee
Journal:  Mol Cell Biochem       Date:  1995-02-23       Impact factor: 3.396

6.  Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins.

Authors:  S L Schissel; J Tweedie-Hardman; J H Rapp; G Graham; K J Williams; I Tabas
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

7.  Reduction in alkaline sphingomyelinase in colorectal tumorigenesis is not related to the APC gene mutation.

Authors:  Erik Hertervig; Ake Nilsson; Mef Nilbert; Rui-Dong Duan
Journal:  Int J Colorectal Dis       Date:  2003-03-04       Impact factor: 2.571

8.  Development of intestinal alkaline sphingomyelinase in rat fetus and newborn rat.

Authors:  Jan Lillienau; Yajun Cheng; Ake Nilsson; Rui-Dong Duan
Journal:  Lipids       Date:  2003-05       Impact factor: 1.880

9.  Identification, partial purification, and localization of a neutral sphingomyelinase in rabbit skeletal muscle: neutral sphingomyelinase in skeletal muscle.

Authors:  N Ghosh; R Sabbadini; S Chatterjee
Journal:  Mol Cell Biochem       Date:  1998-12       Impact factor: 3.396

10.  In vitro effects of fat, FA, and cholesterol on sphingomyelin hydrolysis induced by rat intestinal alkaline sphingomyelinase.

Authors:  Jian-Jun Liu; Ake Nilsson; Rui-Dong Duan
Journal:  Lipids       Date:  2002-05       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.